Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tongshu Biotech is a leading Chinese high-tech enterprise specializing in precision oncology and molecular diagnostics. The company develops and commercializes high-throughput sequencing (NGS) and PCR-based diagnostic kits for cancer screening, companion diagnostics, and minimal residual disease (MRD) monitoring. Their flagship OncoVee platform provides comprehensive genomic profiling to guide personalized treatment for various solid tumors. With dual headquarters and manufacturing bases in Shanghai and Nanjing, the company supports clinical decision-making through a robust portfolio of NMPA-approved IVD products and centralized laboratory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tongshu Biotech.